Condition category
Cancer
Date applied
13/09/2005
Date assigned
11/11/2005
Last edited
09/05/2012
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr Ian Kunkler

ORCID ID

Contact details

Oncology Department
Western General Hospital
Crewe Road South
Edinburgh
EH4 2XU
United Kingdom
+44 (0)131 537 2213
iankunkler@yahoo.com

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

1217319

Study information

Scientific title

Acronym

TELEMAM

Study hypothesis

Decision making in breast cancer management at a multidisciplinary team (MDT) meeting is as clinically effective as face-to-face meetings and achieved at lower cost.

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Breast cancer

Intervention

Randomised standard face-to-face 'on site' multidisciplinary meetings for breast cancer management (MDTs) at Dumfries and Dunfermline (Arm 1) versus MDTs on Dumfries and Dunfermline patients linked by telemedicine between Dumfries and Edinburgh, and Dunfermline and Edinburgh (Arm 2).

Intervention type

Other

Phase

Not Applicable

Drug names

Primary outcome measures

1. Satisfaction with communication process of multidisciplinary decision making for each patient (Interpersonal Communication Satisfaction Scale)
2. Costs of face-to-face and telemedicine delivered decision making
3. Compliance with Scottish Intercollegiate Guidelines Network (SIGN) guidelines of best practice for breast cancer

Secondary outcome measures

1. Pre- and post-trial attitudes to face-to-face and telemedicine delivered multidisciplinary clinics (Personal Report of Communication Apprehension)
2. Measures of objective patterns of interaction
3. Subjective measures of interaction (Group Behaviour Questionnaire, Group Behaviour Inventory, Group Dimensions Description Questionnaire)
4. Communication content (Interaction Process Analysis)
5. General dimensions of output (satisfaction with communication, group atmosphere, involvement, trust and agreement)

Overall trial start date

24/04/2003

Overall trial end date

31/07/2005

Reason abandoned

Eligibility

Participant inclusion criteria

1. Histologically proven breast cancer
2. Requiring decision on treatment of primary or recurrent breast cancer

Participant type

Patient

Age group

Adult

Gender

Female

Target number of participants

230

Participant exclusion criteria

Does not match inclusion criteria

Recruitment start date

24/04/2003

Recruitment end date

31/07/2005

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Oncology Department
Edinburgh
EH4 2XU
United Kingdom

Sponsor information

Organisation

UK Department of Health Research and Development

Sponsor details

Dr R Curry and Mr W Maton-Howarth
Department of Health Research and Development
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)207 210 4850
richard.curry@imperial.ac.uk

Sponsor type

Government

Website

http://www.dh.gov.uk

Funders

Funder type

Government

Funder name

Department of Health (UK) - Research and Development

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

Big Lottery Fund (UK)

Alternative name(s)

Funding Body Type

private sector organisation

Funding Body Subtype

other non-profit

Location

United Kingdom

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

1. 2005 protocol in http://www.ncbi.nlm.nih.gov/pubmed/16124136
2. 2007 results in http://www.ncbi.nlm.nih.gov/pubmed/17962011

Publication citations

  1. Protocol

    Kunkler IH, Fielding RG, Brebner J, Prescott R, Maclean JR, Cairns J, Chetty U, Neades G, Walls A, Bowman A, Dixon JM, Gardner T, Smith M, MacCoubrey J, Lee AJ, Swann S, Mcnab M, Wilson J, Nawroz I, A comprehensive approach for evaluating telemedicine-delivered multidisciplinary breast cancer meetings in southern Scotland., J Telemed Telecare, 2005, 11 Suppl 1, 71-73.

  2. Results

    Kunkler IH, Prescott RJ, Lee RJ, Brebner JA, Cairns JA, Fielding RG, Bowman A, Neades G, Walls AD, Chetty U, Dixon JM, Smith ME, Gardner TW, Macnab M, Swann S, Maclean JR, TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making., Eur. J. Cancer, 2007, 43, 17, 2506-2514, doi: 10.1016/j.ejca.2007.08.026.

Additional files

Editorial Notes